Drug Approval | August 16, 2021
Zydus Cadila receives final approval for Mesalamine extended-release capsules
The group has a total of 320 ANDA approvals
The group has a total of 320 ANDA approvals
The MoU was signed on World Organ Donation Day which falls on August 13
It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
Anti-malaria API facility will be operational in 15-18 months
The company is eligible for 12 months exclusivity from launch
It’s an AB-rated generic therapeutic version of Durezol
SAB-185 is currently being evaluated in NIH-sponsored Phase 2/3 adaptive trial
Wastewater surveillance is becoming increasingly critical for community health monitoring for detecting COVID-19 outbreaks and the spread of other infectious diseases
Subscribe To Our Newsletter & Stay Updated
